
SOHO Brazil 2024
3L in CLL: The Best Options in a Patient Double-Refractory to Covalent BTKi and to BCL-2 Inhibitor
By
SOHO Brazil 2024
FEATURING
Jan Burger
By
SOHO Brazil 2024
FEATURING
Jan Burger
556 views
July 11, 2024
Chapters
Exploring Third-Line CLL Treatment
00:00
Sequencing Treatment After BTK Inhibitor Failure
05:47
Comments 0
Login to view comments.
Click here to Login